Browse the Event Guide to Discover:
18+
industry leading speakers from the likes of NeuroTherapia, Roche, RespireRX Pharmaceuticals, GB Sciences, Neuropathix, and Artelo Biosciences
6
hours of intimate pre-conference workshop discussions, delving into the potential of CB1-targeting therapies for obesity and diabetes treatment and navigating the complex regulatory landscape for cannabinoid research
8+
hours of dedicated networking time across speed networking, roundtable discussions, panels and more
1
scientific poster session, giving you the opportunity to display your own research to this diverse audience of discovery, preclinical and clinical cannabinoid and ECS-targeting drug development experts
